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Abstract 
Background: Young adults (18–39 year-olds) have the lowest hypertension control rates among adults with hyper-
tension in the United States. Unique barriers to hypertension management in young adults with primary care access 
compared to older adults have not been evaluated. Understanding these differences will inform the development of 
hypertension interventions tailored to young adults. The goals of this multicenter study were to explore primary care 
providers’ perspectives on barriers to diagnosing, treating, and controlling hypertension among young adults with 
regular primary care.
Methods: Primary care providers (physicians and advanced practice providers) actively managing young adults 
with uncontrolled hypertension were recruited by the Wisconsin Research & Education Network (WREN), a statewide 
practice-based research network. Semi-structured qualitative interviews were conducted in three diverse Midwestern 
clinical practices (academic, rural, and urban clinics) using a semi-structured interview guide, and content analysis was 
performed.
Results: Primary care providers identified unique barriers across standard hypertension healthcare delivery practices 
for young adults. Altered self-identity, greater blood pressure variability, and unintended consequences of medication 
initiation were critical hypertension control barriers among young adults. Gender differences among young adults 
were also noted as barriers to hypertension follow-up and antihypertensive medication initiation.
Conclusions: Tailored interventions addressing the unique barriers of young adults are needed to improve popula-
tion hypertension control. Augmenting traditional clinic structure to support the “health identity” of young adults and 
self-management skills are promising next steps to improve hypertension healthcare delivery.
Keywords: Qualitative research, Hypertension, Ambulatory care, Health behavior, Medication adherence, Primary 
healthcare
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Background
Hypertension is the most common reversible risk fac-
tor for cardiovascular disease [1]. Approximately 20% of 
young adults (18–39  year-olds) have hypertension and 
increased risk of heart failure, stroke, and chronic kidney 
disease [2–5]. Hypertension control reduces morbidity 
[6, 7] and healthcare costs [8] in young adults. Yet, only 
36% of young adults with hypertension have it controlled, 
compared to 58% of middle-aged and 54% of older adults 
[5]. Sources of such a wide gap in hypertension control 
rates between young and mid-to-older adults are not well 
understood. In fact, once antihypertensive medication is 
initiated, young adults have higher control rates (70%) 
than mid-to-older adults [9].
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Despite notably poor hypertension control rates, 
hypertension remains an under-recognized cardiovas-
cular disease risk factor for young adults. Our previ-
ous research demonstrated significant delays for young 
adults to receive an initial hypertension diagnosis [10]. 
Although lifestyle modifications is important therapy for 
all young adults with hypertension [11, 12], we demon-
strated low rates of lifestyle counseling for young adults 
with incident (new) hypertension [13]. Additionally, 
among young adults with severe hypertension (stage 
2: ≥160/100  mmHg), we documented significant delays 
(years) in providers combining lifestyle modification 
counseling [13] with an initial antihypertensive medica-
tion [14]. Multiple studies have also assessed barriers to 
hypertension control [15–18]. However, understand-
ing the barriers specific to young adults is an important 
next step to develop effective hypertension interventions. 
Therefore, we conducted a multicenter qualitative study 
of primary care providers (physicians and advanced prac-
tice providers) caring for young adults with hypertension 
to assess their recognized barriers to hypertension diag-
nosis, treatment (lifestyle and medication), and control 
specific to this population. A separate manuscript focuses 




This study was approved by the University of Wisconsin-
Madison Health Sciences Institutional Review Board. 
One-on-one, 60-min provider interviews were conducted 
at three Family Medicine/Family Practice clinics within 
three different counties in Wisconsin, including an aca-
demic community clinic, urban clinic, and a rural clinic. 
One-on-one interviews, instead of focus groups, was the 
selected approach to provide an environment for physi-
cians to freely share personal information about their 
practice patterns, identified practice barriers, and knowl-
edge gaps on hypertension clinical care for young adults. 
Our goal was to promote representation from healthcare 
providers across diverse practice settings and geographic 
locations. Providers were recruited by the Wisconsin 
Research & Education Network (WREN), a statewide 
practice-based research network, and invited to partici-
pate via email and at clinical staff meetings. Purposive 
non-random sampling was performed with predefined 
criteria [20]. Inclusion criteria included practicing phy-
sicians [medical doctor (MD) or doctor of osteopathic 
medicine (DO)] and advanced practice providers (phy-
sician assistants, nurse practitioners, advanced practice 
nurse practitioners) with a clinic panel that includes 
young adults (18–39 year-olds) with uncontrolled hyper-
tension. Across all sites, advanced practice providers were 
included in the study because they shared patient panels 
with the physicians. It is common across sites that many 
patients have follow-up visits with the advanced prac-
tice provider. The rural clinical site was the only Family 
Medicine/Family Practice clinic in the county; the urban 
and academic clinical sites were the largest ambulatory 
healthcare delivery systems in their respective coun-
ties and were typical of hypertension clinical care in the 
area. All interviews were conducted by a trained research 
assistant at each provider’s clinic in a closed office to 
maintain privacy. Prior to starting the interview, all pro-
viders reviewed an IRB-approved summary sheet about 
the research study and provided verbal consent; writ-
ten consent (signature) was waived by the University of 
Wisconsin-Madison Health Sciences Institutional Review 
Board. All interviews were audio recorded, professionally 
transcribed verbatim, and reviewed for accuracy. Provid-
ers received a $100 honorarium for participation. The 
data was collected between May 2014 and October 2014.
A semi-structured interview guide was developed 
based on previous literature of barriers to hypertension 
control across populations [10, 14, 15, 17, 21–24] and 
barriers to managing other cardiovascular risk factors 
among adolescents/young adults (e.g., diabetes [25, 26]). 
Provider participants were asked a total of 16 questions 
on the following topics: (1) their personal blood pres-
sure threshold to diagnose hypertension and start life-
style modification and/or antihypertensive medication, 
(2) reluctance or hesitancy among themselves or their 
colleagues to diagnose hypertension and/or start medi-
cation, and (3) hypertension guideline applicability for 
young adults compared to middle-aged and older adults. 
Samples questions are provided in Table 1.
Qualitative data analysis
Our purposive sample size was determined on the basis 
of theoretical saturation [20]. Data analysis and collection 
occurred iteratively with adjustment in question content 
to allow for additional probing [27, 28]. Directed content 
analysis was used to code the interview transcripts [29]. 
Initially, transcripts were read to achieve immersion and 
context. All codes were then determined from the tran-
scribed text, rather than being generated a priori (see 
Additional file 1). Two investigators without prior clini-
cal hypertension experience (RW and JL) independently 
coded all transcripts. Emergent codes were generated in 
initial readings of the transcripts by each coder. The cod-
ers then met bimonthly for a multidisciplinary review 
to adjudicate differences by consensus and refine codes. 
When the final coding scheme was generated after com-
pletion of all interviews, it was applied to all transcripts 
by a single coder (JL). Data were managed with Micro-
soft Excel with written protocols and memos of coding 
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and analysis across transcripts. Provider demographic 
characteristics (gender, years in practice since completing 
training, type of practice setting (academic, urban, rural) 
and degree [medical doctor (MD), doctor of osteopathic 
medicine (DO), nurse practitioner (NP), physician assis-
tant (PA)]) were obtained from self-report and described 
as continuous and categorical descriptive variables.
Results
Participant characteristics
There were a total of 15 Family Medicine/Family Prac-
tice providers across all three clinic sites (11 physicians 
and 4 nurse practitioners). Physicians assistants were not 
interviewed; either they did not meet inclusion criteria or 
did not practice in the selected clinics. A total of 10 pro-
viders (8 physicians and 2 nurse practitioners) accepted 
the invitation; 9 completed interviews (one physician 
canceled secondary to an urgent medical condition). 
The nurse practitioners and physicians reported simi-
lar responses. Table  2 demonstrates that five of the ten 
providers were female (2 nurse practitioners, 3 medical 
doctors) which is typical of practice across clinical sites. 
All interviewed providers reported being of White race 
and practiced in predominantly White communities. The 
mean (standard deviation) years in medical practice, after 
completing training, was 14.4 (±10.2) years.
Guidelines and young adults
All providers felt that the Joint National Committee 
8 (JNC 8) guidelines were applicable to young adults 
the same as middle-aged and older adults. Provid-
ers’ responses unanimously reflected guideline rec-
ommendations that at least 2–3 blood pressures from 
separate visits are needed to confirm elevated blood 
pressures [12, 30]. In addition, all providers were in 
agreement that 3–6  months of lifestyle modifications 
were needed prior to medication initiation, unless the 
patient had significantly elevated hypertension (i.e., stage 
2, ≥160/100 mmHg).
Reported spectrum of clinical care and barriers
Figure  1 summarizes clinical care transition points that 
were identified as barriers among the interviewed pri-
mary care providers. Compared to middle-aged and older 
adults, all providers highlighted greater challenges tran-
sitioning young adults to the next stage of hypertension 
management. This most frequently included going from 
(a) observed blood pressure elevations to an initial hyper-
tension diagnosis and (b) lifestyle modifications alone to 
lifestyle modifications with blood pressure medication.
Barrier: psychosocial consequence of a hypertension 
diagnosis
All primary care providers identified one or more psy-
chosocial consequences as a barrier to providing an ini-
tial hypertension diagnosis. The most common theme 
was that a hypertension diagnosis resulted in a “sick 
identity” for young adults. Usual management of elevated 
blood pressures requires young adults to: (1) return more 
frequently to the clinic for blood pressure checks and 
(2) sit in clinic waiting rooms usually filled with older 
patients. This promotes a “sick identity” and precipitates 
young adults’ resistance to achieving hypertension con-
trol. Other psychosocial consequences discussed less 
frequently were anxiety and fear associated with a new 
hypertension diagnosis.
Table 1 Topic guide and sample primary care provider interview questions
There were a total of 16 interview questions
Guideline applicability In your experience, are the JNC (Joint National Committee) 8 guidelines applicable to young adults?
Hypertension diagnosis In a young adult with multiple elevated blood pressures, is there a point you might consider a diagnosis of hypertension?
Would your thoughts and plans for a hypertension diagnosis differ if the patient was older, for example, 55 years old?
Hypertension treatment If a young adult has elevated blood pressures on multiple visits, is there a point you might consider starting a blood pressure 
medication?
Would your thoughts and plans for starting blood pressure medication differ if the patient was 55 years old?
Table 2 Family practice/family medicine primary care pro-
vider characteristics




Title Clinic practice setting Number of years in  
clinical practice after  
training completion





M MD Rural Community Clinic 7
M MD 34
F MD 14
F MD Urban Community Clinic <1 year (0.7 months)
F MD 13
F NP 5
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•  Provider 005: “I think the obstacle is they have to come 
here to this place (clinic), you know, where they do not 
see themselves in a sick role. And yet you come here 
and… you know, you’re in the waiting room and these 
are people that are sick …where old and sick people 
come. Maybe we should rethink of where they go and 
what their self-image is.”
Despite this being a critical barrier, none of the provid-
ers could provide alternative healthcare delivery strate-
gies to support young adult’s identity when diagnosing 
hypertension.
Barrier: a possible false hypertension diagnosis
The majority of primary care providers were concerned 
about a false hypertension diagnosis and possible future 
negative implications, such as obtaining life insurance.
•  Provider 005: “It still might affect someone who 
wanted to buy life insurance to protect their family. 
You put hypertension as a diagnosis and it really isn’t, 
it really was episodic elevated blood pressures, then 
there could be a problem. So I don’t jump on the diag-
nosis right away.”
When transitioning from recognizing elevated blood 
pressures to documenting an initial hypertension diag-
nosis, all primary care providers were concerned about 
greater clinic blood pressure variability among young 
adults, especially from “reversible” causes (e.g., stress, 
white coat syndrome, caffeine, alcohol, tobacco use).
  • Provider 005: “Could be smoking, could be caffeine, 
could be drugs, could be stress, could be all kinds of 
things and maybe we should follow up.”
  • Provider 006: “I’ve had young people who had a 
bunch of energy drinks… before they came in… I 
mean …is there some reason that this (elevated blood 
pressure) is happening now that could be reversible 
basically?”
  • Provider 003: “A lot of them (young adults) lie, and 
don’t always want to tell you the truth and don’t 
always want to say what might be in their urine drug 
screen…”
Given concerns about blood pressure variability and 
false hypertension diagnoses, the lack of out-of-clinic 
blood pressures was reported as a significant contributor 





























Fig. 1 “Barrier points” to deliver hypertension care to young adults. This figure summarizes the most common emergent themes during the 60-min 
one-on-one Family Practice/Family Medicine provider interviews about barriers and challenges to diagnosis, treat, and control hypertension in 
young adults
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adults. All providers reported more health insurance 
coverage among young adults secondary to the Afford-
able Care Act; however, a recurring policy issue was the 
lack of standard coverage for home blood pressure moni-
tors. Additionally, although 24-h ambulatory blood pres-
sure monitoring is covered by most medical insurance to 
exclude white coat hypertension, transportation issues 
and compliance remain as primary barriers for complet-
ing the study among young adults.
•  Provider 005: “…Why not do something for young 
adults, you know? You could have this (blood pressure 
monitor) in your house and we could monitor it. And 
realistically, how much do you really need to be in the 
clinic talking to the doctor for just monitoring when 
monitoring is more important at that age, you know?”
Attention deficit hyperactivity disorder medications 
and oral contraceptives were commonly mentioned as 
contributors to elevated blood pressure in young adults. 
Although adults ≥40 years old are on similar medications 
[31], our providers felt that these medications may have a 
greater contribution to elevated blood pressures in young 
adults and were uncertain about adjusting or discon-
tinuing these medications versus adding blood pressure 
medication to lower blood pressure. None of the provid-
ers were able to report a resource available to guide treat-
ment decision.
  • Provider 003: “Well I can think of some young 
adults and teenagers who are gaining weight… being 
on classic ADHD meds. And so I see blood pres-
sure moving up to a point where I’m going to have 
to say, ‘oops’. And that’s a really big issue because… 
very often we’ve really carved that medicine out for 
them… since they were a kid. So that’s a tough thing.”
  • Provider 004: “Usually postmenopausal women aren’t 
on, you know—they could be on low-dose estrogen, 
but usually it’s just the young women worrying about 
hypertension caused by their birth control pill.”
Barrier: visit adherence
The majority of our providers reported lower patient 
visit adherence among young adults (i.e., higher no-show 
clinic rates) compared to older adults. During interviews, 
providers reported numerous life stressors, conflicting 
demands, transportation barriers, and/or more frequent 
changes in healthcare systems.
•  Provider 001: “Right now a lot of the system relies on 
us telling a patient to schedule a follow-up, ideally what 
I try to do is schedule follow-ups at the end of it (clinic 
visit), so it’s in place. But even then, people, you know, 
cancel. People no-show. You lose track of people. 
They’ve got things to do.”
However, possible adverse health effects associated 
with low visit adherence after starting blood pressure 
medication was reported by approximately one-third of 
providers. Per guidelines, some blood pressure medica-
tions (e.g., diuretics, ace-inhibitors, angiotensin receptor 
blockers, aldosterone antagonists) require timely follow-
up labs, including electrolyte and renal function monitor-
ing. These providers shared concerns about a risk/benefit 
ratio of starting a blood pressure medication in a popula-
tion with low visit adherence.
•  Provider 008: “Certain medications, we need to moni-
tor their electrolytes. You know, they’ll take medica-
tions but they won’t come back in and get their potas-
sium drawn and they have to go the ER for muscle 
cramps… You always worry about the side effects of 
any medication that you start somebody on… are they 
going to come back?”
Barrier: gender differences in blood pressure management
The large majority of the primary care provider inter-
views highlighted gender differences for two recurring 
topics: (1) clinic blood pressure follow-up and (2) preg-
nancy risks with blood pressure medication initiation. Of 
the providers that reported gender-related barriers, over 
one-third reported it was easier to achieve blood pres-
sure follow-up among young women because of visits 
required for contraception or because they coordinated 
visits for other household members (e.g., children). How-
ever, most providers reported that because young adult 
women are of child-bearing age, they felt challenged and 
were more cautious to start blood pressure medication 
due to pregnancy risks.
  • Provider 006: “Women can’t escape me as much as 
men. They often need to come in for contraception 
or for other things and so I can kind of check up on 
them. So it’s easier for me to keep them in the fold… 
men could go a long time without seeing a doctor.”
  • Provider 003: “I struggle with young women, because 
of risks in getting pregnant. That’s a tough one (start-
ing blood pressure medication).”
Barrier: reluctance to start blood pressure medication
All of the providers shared that it was “easier” and they 
were “less hesitant” to provide an initial hypertension 
diagnosis to young adults compared to starting medica-
tion. The majority of the providers reflected that they are 
hesitant to require young adults to make a commitment 
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to lifelong medication. Reluctance or hesitancy with 
medications for other chronic conditions was not dis-
cussed in this study.
  • Provider 002: “…You know, making a diagnosis or 
labeling somebody is one thing, putting them on 
medication is another. With older individuals, I think 
on average, we have people more commonly on med-
ications. So, adding something in isn’t as much of 
a change as the young healthy person with a single 
diagnosis and all of a sudden they’re committed to 
take… the medication once or twice… a day.”
  • Provider 001: “Sometimes it feels like you’re just giv-
ing in and just medicating, you know, at an early age. 
Once you sort of go down that path, you feel like, 
they’re probably going to be on this indefinitely… I 
think that there’s a reluctance to medicate… because 
of a person’s age and the idea that they do have that 
much time ahead of them, even though the flip side 
of it is there’s all the more rationale to treat them.”
All of the providers also stressed greater difficulty 
obtaining young adults’ acceptance of starting antihy-
pertensive medication compared to their older adult 
patients. Additional research is needed to determine if 
a provider’s hesitancy or reluctance is reflected onto the 
patient.
  • Provider 005: “And I think this is a little more diffi-
cult in young adults. … you know, a 60 year-old who 
is very afraid of having a heart attack and dying and 
leaving the family with nothing, they’re pretty easy. 
You get someone who is 25 years old and you say you 
have hypertension; but I think that there’s that fac-
tor of ‘I’m 25 years old. I’m going to live forever.’ So I 
think there’s an amount of convincing that you need 
to do in a young adult that you don’t need to do in an 
older adult.”
  • Provider 006: “They’re younger; it’s really harder for 
them to take it as seriously. So both sticking with 
kind of a healthy diet and with exercise and with tak-
ing their medications, is probably the biggest chal-
lenge.”
However, once the clinical decision was made to con-
sider antihypertensive medication, providers were 
concerned that medication initiation would promote 
continued unhealthy behaviors.
  • Provider 005: “If I start the medication, does that 
mean that they then disregard all their other fac-
tors… So okay, I’ll take a blood pressure pill and then 
I’m going to you know, eat all the salt I want and eat 
all the fat and gain weight and sit around and do 
nothing.”
  • Provider 008: “Do they kind of view it as a crutch, 
you know? Get their blood pressure down in a nor-
mal range and then kind of go back to eating what-
ever they want or not exercising at all.”
Barriers to hypertension control across age groups
Our providers shared themes that they felt played a 
greater role in their practice when managing hyperten-
sion in young adults compared to older adults: (a) limited 
clinic time, (b) financial barriers (e.g., clinic visit co-
payments and medication costs), and (c) limited support 
staff.
  • Provider 001: “The pressures of, you know, clinic 
flow… if you’re lucky you have a 20  min visit to 
address what we know on average is close to three 
problems per visit. Not to use it as an excuse, but I 
think it’s challenging to have effective motivational 
interviews and outcomes with patients when you 
have probably 5 min.”
  • Provider 003: “Cost is another issue. Although we’ve 
been working around that for years. So we try to 
work something out for clinic visits. We have quite a 
few places where we can get $4 meds or $8 meds or 
$10 meds.”
  • Provider 005: “Non-physician providers like nurse 
practitioners and physician assistants would be quite 
helpful, you know, to get them (young adults) to 
come back so we don’t lose people.”
Discussion
There has been extensive prior research on barriers to 
hypertension diagnosis, treatment, and control [15–18, 
21]. However, young adults continue to have the lowest 
hypertension control rates in the United States [5]. To 
our knowledge, this is the first study to describe barriers 
and challenges associated with diagnosing, treating, and 
achieving hypertension control in young adults receiv-
ing regular primary care. All of the providers felt that 
current guidelines (JNC 8) were applicable to young 
adult populations. However, this study identified an 
important unintended consequence of our traditional 
approach to hypertension care—projecting a “sick iden-
tity” onto young adults with elevated blood pressures. 
Our current hypertension guidelines and algorithms 
do not assist providers with this vital issue, highlight-
ing the critical need for additional research and recom-
mendations within this area. A prior qualitative study 
of patient perceptions emphasized the importance of 
reviewing wait times and patients’ perspectives of per-
sonal respect [32].
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Providers’ concern about greater blood pressure vari-
ability is supported by previous research and hyperten-
sion scientific statements [33, 34]. Home blood pressure 
monitoring is recommended to guide hypertension treat-
ment, especially for young adults given their blood pres-
sure variability [33, 35, 36]. Blood pressures measured at 
home average 6–8  mmHg (systolic)/5–6  mmHg (dias-
tolic) lower than clinic values, which can affect provid-
ers’ treatment plans [37]. The lack of out-of-clinic blood 
pressure data was repeatedly reported as a contribu-
tor to delays in a hypertension diagnosis and treatment 
escalation. Unfortunately, providers reported a lack of 
resources to defray costs of home blood pressure moni-
tors since they are not covered by many health insurance 
companies. Longstanding research has demonstrated 
cost savings and fewer physician visits [38] associated 
with home blood pressure monitoring, and expanding 
the affordability and options for out-of-clinic monitors 
should continue to be a health policy focus [39].
Our discussions about differences in managing hyper-
tension in young adults compared to older adults also 
yielded recurring themes of barriers that have been his-
torically present across age groups [15–18, 21]. However, 
visit adherence (i.e., clinic visit no-shows) was an impor-
tant theme, not just for diagnosis and control of hyper-
tension, but also as a safety issue when prescribing blood 
pressure medication to young adults. It may be benefi-
cial to extend hypertension guidelines to address visit 
adherence and not just medication adherence. Surpris-
ingly, some providers were concerned that medication 
initiation promoted young adults to resume or increase 
unhealthy lifestyle behaviors, which resulted in delays 
of prescribing medication in their practice. This high-
lights the need for team-based care to support ongoing 
lifestyle modification counseling, even between visits, to 
support a combined approach to hypertension control 
[40].
Notable gender differences were identified in hyper-
tension care for young adults. In general, young women 
have more opportunities for blood pressure clinic visits 
by being a “captured audience.” Previous literature has 
also demonstrated that young men are less likely to uti-
lize healthcare than women [41]. However, antihyperten-
sive medication initiation among young women poses a 
greater challenge to primary care providers due to preg-
nancy risks. Ongoing hypertension quality improvement 
interventions should address these gender-based barriers 
to increase population hypertension control.
Strengths of this qualitative analysis include a multisite 
design including academic, rural, and urban healthcare 
systems. A separate manuscript summarizes young adult 
patients’ perspectives on hypertension management from 
the same healthcare systems [19]. One limitation is that 
all providers interviewed were Midwestern Family Medi-
cine/Family Practice practitioners and all had low rates 
of Latino patients on their patient panels. Therefore, 
this data may not encompass other barriers encountered 
in managing hypertension in other regions or among 
some minority races/ethnicities. In addition, the provid-
ers interviewed represented patients with primary care 
access and the identified barriers may not encompass 
other issues associated with young adults without regu-
lar primary care access. All providers across the coun-
ties/clinical sites were of White race and practiced in 
predominantly White communities; however, the state is 
predominantly White. Therefore, our data may not reflect 
additional barriers experienced by providers and patients 
of minority race/ethnicity. In addition, socioeconomic 
status and neighborhood characteristics across practice 
panels were not assessed.
Conclusions
Our qualitative analysis highlights important interven-
tion target areas to hypertension control among young 
adults. Changes to traditional hypertension healthcare 
delivery to support ongoing blood pressure self-manage-
ment and the “health identity” of young adults are needed 
to address their unique barriers.
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versity of Wisconsin-Madison Health Sciences Institutional Review Board.
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